Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
11.54 USD | +1.81% | +3.03% | +2.85% |
04-05 | Arbutus Biopharma Obtains Favorable Court Order in Moderna Patent Lawsuit | MT |
04-04 | Moderna Suffers Setback in Lawsuit by Arbutus | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+2.85% | 9.13B | |
+31.37% | 588B | |
-2.72% | 364B | |
+20.23% | 326B | |
+5.38% | 285B | |
+14.83% | 239B | |
+9.93% | 210B | |
-6.95% | 200B | |
+10.95% | 167B | |
+0.52% | 161B |
- Stock Market
- Equities
- ROIV Stock
- News Roivant Sciences Ltd.
- Goldman Sachs Lowers Roivant Sciences; Price Target to $12 From $15, Maintains Buy Rating